Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Saint John's Medical Plaza Pharmacy
WARNING LETTER
•Saint John's Medical Plaza Pharmacy

Saint John's Medical Plaza Pharmacy – FDA Warning Letter

Record Details

On January 7, 2008, the FDA issued a Warning Letter to Saint John's Medical Plaza Pharmacy, specifically to Ms. Nancy Mavadat, following a review of the firm's website, www.saintjohnpharmacy.com. The letter identified multiple significant violations of the Federal Food, Drug, and Cosmetic Act (FDCA). Firstly, the firm's compounded hormone therapy drugs were deemed misbranded under Section 502(a) of the FDCA due to false and misleading claims on its website. These claims included unsubstantiated efficacy benefits, such as treating heart disease, Alzheimer's, and improving mood, as well as unsubstantiated assertions that the drugs were "bio-identical." The FDA stated it was unaware of substantial evidence to support these claims. Secondly, the pharmacy was found to be compounding hormone therapy drugs containing estriol without an FDA-approved new drug application or an FDA-sanctioned investigational new drug (IND) application. This constitutes a violation of Section 505 of the FDCA, rendering these estriol-containing products unapproved new drugs. Finally, these estriol drugs were also cited as misbranded under Section 502(f)(1) of the FDCA because their labeling failed to bear adequate directions for use. The FDA requires the firm to take prompt corrective action within fifteen working days, providing a written response detailing steps taken to address and prevent recurrence of these violations. Failure to comply could lead to legal actions like seizure or injunction, and impact federal contract eligibility.

Company
Saint John's Medical Plaza Pharmacy
Product type
Drugs
Office
Los Angeles District Office
People
  • Alonza E. Cruse (Director)
  • John J. Stamp
  • Pamela B. Schweikert
View Company Profile

ID · 1ab9bd69-7db8-4536-a948-db954834c6c4

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 352(a)21 U.S.C. 35521 U.S.C. 352(f)(1)21 U.S.C. 321(n)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 352(0(1)21 CFR 201.11521 U.S.C. 353a

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Saint John's Medical Plaza Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.